Stratification analysis by cancer type indicated that AhR rs2066853 polymorphism was not significantly associated with the risk of lung cancer (AA+GA vs. GG: OR = 0.904, 95%CI = 0.721–1.134, P = 0.384, Fig. 3b; other models, Additional file 4, 5, and 6: Fig. S4b-S6b) or breast cancer (AA+GA vs. GG: OR = 1.014, 95%CI = 0.791–1.300, P = 0.912, Fig. 3b; other models, Additional file 4, 5, and 6: Fig. S4b-S6b) in any of the models. This evidence concerns the gene AHR and cancer.